Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

被引：0
|
作者：
Kannie Chim
Sharon X Xie
Carrie T Stricker
Qing S Li
Robert Gross
John T Farrar
Angela DeMichele
Jun J Mao
机构：
[1] University of Pennsylvania,Department of Family Medicine and Community Health
[2] Perelman School of Medicine at the University of Pennsylvania,Center for Clinical Epidemiology and Biostatistics
[3] Perelman School of Medicine at the University of Pennsylvania,Abramson Cancer Center
[4] Perelman School of Medicine at the University of Pennsylvania,Department of Medicine
来源：
BMC Cancer | / 13卷
关键词：
Aromatase inhibitor; Joint pain; Adherence; Adverse effects; Musculoskeletal; Breast cancer; Pain diagnosis; Pain management; Survivorship;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Aromatase inhibitors and breast cancer
    Chumsri, Saranya
    Brodie, Angela
    [J]. HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2012, 9 (02) : 119 - 126
  • [32] Aromatase inhibitors and breast cancer
    Brodie, AMH
    Njar, VCO
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (04) : 10 - 20
  • [33] Aromatase inhibitors for breast cancer
    Susanne Briest
    Nancy E. Davidson
    [J]. Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 215 - 228
  • [34] Aromatase Inhibitors and Breast Cancer
    Macedo, Luciana Furtado
    Sabnis, Gauri
    Brodie, Angela
    [J]. STEROID ENZYMES AND CANCER, 2009, 1155 : 162 - 173
  • [35] Aromatase inhibitors in breast cancer
    Hiscox, Stephen
    Davies, Eleri Lloyd
    Barrett-Lee, Peter
    [J]. MATURITAS, 2009, 63 (04) : 275 - 279
  • [36] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time
    Shaaban, Adnan
    Petersen, Ashley
    Beckwith, Heather
    Florea, Natalia
    Potter, David A.
    Yee, Douglas
    Vogel, Rachel I.
    Duprez, Daniel
    Blaes, Anne H.
    [J]. CARDIO-ONCOLOGY, 2024, 10 (01)
  • [37] Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors
    Breckenridge, Lynn M.
    Bruns, Gina L.
    Todd, Briana L.
    Feuerstein, Michael
    [J]. PSYCHO-ONCOLOGY, 2012, 21 (01) : 43 - 53
  • [38] Endothelial dysfunction in breast cancer survivors on aromatase inhibitors (AIs) over time
    Blaes, A. H.
    Petersen, A.
    Beckwith, H.
    Potter, D.
    Florea, N.
    Yee, D.
    Vogel, R.
    Duprez, D.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [39] Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors
    Mao, Huijuan
    Bao, Ting
    Shen, Xueyong
    Li, Qing
    Seluzicki, Christina
    Im, Eun-Ok
    Mao, Jun J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 101 : 47 - 54
  • [40] Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors
    Fansa, Sima
    Ghusn, Wissam
    Tama, Elif
    Nicolalde, Bryan
    Anazco, Diego
    Andre, Stacy D. '
    Faubion, Stephanie S.
    Shufelt, Chrisandra L.
    Acosta, Andres
    Andrade, Maria D. Hurtado
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2024,
12345